{
  "id": [
    "32383371"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32383371"
  ],
  "pmcid": [
    "PMC7211516"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7211516"
      ]
    }
  ],
  "doi": [
    "10.3346/jkms.2020.35.e176"
  ],
  "title": [
    "Perspectives of Immune Therapy in Coronavirus Disease 2019."
  ],
  "authorString": [
    "Gasparyan AY, Misra DP, Yessirkepov M, Zimba O."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Gasparyan AY"
          ],
          "firstName": [
            "Armen Yuri"
          ],
          "lastName": [
            "Gasparyan"
          ],
          "initials": [
            "AY"
          ],
          "authorId": [
            {
              "_": "0000-0001-8749-6018",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK. a.gasparyan@gmail.com."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Misra DP"
          ],
          "firstName": [
            "Durga Prasanna"
          ],
          "lastName": [
            "Misra"
          ],
          "initials": [
            "DP"
          ],
          "authorId": [
            {
              "_": "0000-0002-5035-7396",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Yessirkepov M"
          ],
          "firstName": [
            "Marlen"
          ],
          "lastName": [
            "Yessirkepov"
          ],
          "initials": [
            "M"
          ],
          "authorId": [
            {
              "_": "0000-0003-2511-6918",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Zimba O"
          ],
          "firstName": [
            "Olena"
          ],
          "lastName": [
            "Zimba"
          ],
          "initials": [
            "O"
          ],
          "authorId": [
            {
              "_": "0000-0002-4188-8486",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine No. 2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine."
              ]
            }
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-8749-6018",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-5035-7396",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0003-2511-6918",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-4188-8486",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "18"
      ],
      "volume": [
        "35"
      ],
      "journalIssueId": [
        "2953283"
      ],
      "dateOfPublication": [
        "2020 May"
      ],
      "monthOfPublication": [
        "5"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-05-01"
      ],
      "journal": [
        {
          "title": [
            "Journal of Korean medical science"
          ],
          "ISOAbbreviation": [
            "J. Korean Med. Sci."
          ],
          "medlineAbbreviation": [
            "J Korean Med Sci"
          ],
          "NLMid": [
            "8703518"
          ],
          "ISSN": [
            "1011-8934"
          ],
          "ESSN": [
            "1598-6357"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "e176"
  ],
  "abstractText": [
    "The global fight against coronavirus disease 2019 (COVID-19) is largely based on strategies to boost immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent its severe course and complications. The human defence may include antibodies which interact with SARS-CoV-2 and neutralize its aggressive actions on multiple organ systems. Protective cross-reactivity of antibodies against measles and other known viral infections has been postulated, primarily as a result of the initial observations of asymptomatic and mild COVID-19 in children. Uncontrolled case series have demonstrated virus-neutralizing effect of convalescent plasma, supporting its efficiency at early stages of contracting SARS-CoV-2. Given the variability of the virus structure, the utility of convalescent plasma is limited to the geographic area of its preparation, and for a short period of time. Intravenous immunoglobulin may also be protective in view of its nonspecific antiviral and immunomodulatory effects. Finally, human monoclonal antibodies may interact with some SARS-CoV-2 proteins, inhibiting the virus-receptor interaction and prevent tissue injury. The improved understanding of the host antiviral responses may help develop safe and effective immunotherapeutic strategies against COVID-19 in the foreseeable future."
  ],
  "affiliation": [
    "Departments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK. a.gasparyan@gmail.com."
  ],
  "publicationStatus": [
    "epublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Coronavirus"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TH"
                  ],
                  "qualifierName": [
                    "therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TH"
                  ],
                  "qualifierName": [
                    "therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunoglobulins, Intravenous"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antibodies, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "BL"
                  ],
                  "qualifierName": [
                    "blood"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunization, Passive"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Antibodies",
        "Immunotherapy",
        "Vaccination",
        "Comorbidities",
        "Convalescent Serum",
        "Covid-19"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antibodies, Viral"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Immunoglobulins, Intravenous"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.3346/jkms.2020.35.e176"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7211516"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7211516?pdf=render"
          ]
        }
      ]
    }
  ],
  "commentCorrectionList": [
    {
      "commentCorrection": [
        {
          "id": [
            "32533292"
          ],
          "source": [
            "MED"
          ],
          "reference": [
            "Rheumatol Int. 2020 Aug;40(8):1343-1345"
          ],
          "type": [
            "Comment in"
          ],
          "orderIn": [
            "1"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "8"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by-nc"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-05-13"
  ],
  "dateOfCreation": [
    "2020-05-09"
  ],
  "firstIndexDate": [
    "2020-05-12"
  ],
  "fullTextReceivedDate": [
    "2020-07-10"
  ],
  "dateOfRevision": [
    "2020-05-16"
  ],
  "electronicPublicationDate": [
    "2020-05-11"
  ],
  "firstPublicationDate": [
    "2020-05-11"
  ]
}